Study lays groundwork for potential bipolar disorder therapies

Bipolar disorder, which affects nearly eight million Americans, takes a toll not only on patients, but also on their families and communities. In the new study, the researchers focused on a gene known as PDE10A, one of the many genes that has been linked to bipolar disorder, and the proteins this gene produces.